Journal of Gastrointestinal Oncology

The Journal of Gastrointestinal Oncology (J Gastrointest Oncol, ISSN: 2078-6891) is a peer-reviewed, open-access medical journal dedicated to advancing the understanding and management of malignancies affecting the gastrointestinal tract. Published by AME Publishing Company, the journal serves as a specialized platform for the dissemination of high-quality research in the field of gastrointestinal oncology. Its scope encompasses a broad range of topics, including the molecular biology, pathology, diagnosis, prevention, and treatment of cancers of the esophagus, stomach, liver, pancreas, biliary tract, colon, rectum, and other digestive organs. The journal publishes a variety of article types to cater to both clinical and translational researchers, including original research articles, comprehensive reviews, meta-analyses, editorials, case reports, and technical notes. Its primary target audience comprises gastroenterologists, oncologists, surgeons, radiologists, pathologists, and basic science researchers focused on digestive system cancers. A notable feature of the journal is its open-access model, ensuring that all published content is freely available to readers worldwide, thereby promoting wider dissemination and impact of research findings. With an Impact Factor of 2.1000 as of 2026, the journal is positioned in the third quartile (Q3) of its subject area, reflecting a solid, reputable standing within the competitive landscape of oncology and gastroenterology literature. While not among the highest-tier journals, it provides a valuable and accessible venue for clinically relevant research and contributes meaningfully to the ongoing dialogue in gastrointestinal oncology.